MEVAC, a leading Egyptian producer of veterinary vaccines, has established itself as a trusted partner in advancing animal health and supporting regional food security. In 2024, the company entered into a strategic partnership with Kemin Industries, a U.S.-based global leader in biotechnology, to introduce advanced biotechnological solutions to Egypt and the wider region.

As part of this collaboration, MEVAC invested EGP 750 million to expand its production capacity, further enhancing Egypt’s pharmaceutical and biotechnology capabilities. This significant investment underscores MEVAC’s commitment to innovation and sustainable growth, while reinforcing Egypt’s position as an emerging hub for biotechnology on the global stage.

Through this partnership, MEVAC not only strengthens its ability to meet the region’s health and safety needs but also contributes to Egypt’s broader vision of developing world-class pharmaceutical and biotech industries.